I
I. Cirera
Researcher at Autonomous University of Barcelona
Publications - 11
Citations - 531
I. Cirera is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Ascites & Hepatorenal syndrome. The author has an hindex of 5, co-authored 11 publications receiving 483 citations.
Papers
More filters
Journal ArticleDOI
Natural history of patients hospitalized for management of cirrhotic ascites.
Ramon Planas,Silvia Montoliu,Belén Ballesté,M. Rivera,Mireia Miquel,Helena Masnou,Jose Antonio Galeras,M.D. Giménez,Justiniano Santos,I. Cirera,Rosa Maria Morillas,Susanna Coll,Ricard Solà +12 more
TL;DR: The survival of cirrhotic patients with first episode of ascite is relatively high, and it is mainly influenced by age and Child-Pugh score at the time of ascites decompensation, as well as by DH development.
Journal ArticleDOI
Incidence and Prognosis of Different Types of Functional Renal Failure in Cirrhotic Patients With Ascites
Silvia Montoliu,Belén Ballesté,Ramon Planas,Ramon Planas,Marco Antonio Álvarez,M. Rivera,Mireia Miquel,Mireia Miquel,Helena Masnou,Helena Masnou,I. Cirera,Rosa Maria Morillas,Rosa Maria Morillas,Susanna Coll,Margarita Sala,M.G. Retortillo,Nuria Cañete,Ricard Solà +17 more
TL;DR: Almost 50% of the cirrhotic patients with ascites developed some type of functional renal failure during the follow-up period; renal failure was associated with worse prognosis.
Journal ArticleDOI
Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients.
Ricard Solà,Marco Antonio Álvarez,Belén Ballesté,Silvia Montoliu,M. Rivera,Mireia Miquel,I. Cirera,Rosa Maria Morillas,Susanna Coll,Ramon Planas +9 more
TL;DR: Although chronic alcohol intake and chronic hepatitis C may progress to cirrhosis and hepatocellular carcinoma, few data are available about survival and probability of developing HCC in decompensated Cirrhosis of both aetiologies.
Journal ArticleDOI
A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C
José A. Carrión,E González-Colominas,Montserrat García-Retortillo,Nuria Cañete,I. Cirera,Susanna Coll,M.D. Giménez,C. Márquez,Victoria Martín-Escudero,P. Castellví,P. Castellví,Ricard Navinés,Juan Ramon Castaño,J.A. Galeras,E. Salas,Felipe Bory,Rocío Martín-Santos,Ricard Solà +17 more
TL;DR: MSP improves patient compliance and increases the efficiency of antiviral treatment in CHC, being cost-effective and dominant in all genotypes.
Journal ArticleDOI
A clinical staging system for cirrhosis: a multicenter cohort study of 1858 patients
Matthias M. Dollinger,G D'Amico,C Villanueva,AK Burroughs,Ramon Planas,R Sola,P Cales,Mario D'Amico,I Garupera,M Garcovich,Alexander Zipprich,RM Morillas,I. Cirera,G. Roquin,Wolfgang E. Fleig,A Colomo,Nuria Cañete,Marco Antonio Álvarez,J Boursier,Linda Pasta +19 more